📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: PharmaMar

1.1 - Company Overview

PharmaMar Logo

PharmaMar

Headquarter: Spain
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of oncology medicines inspired by the sea, discovering antitumor molecules from marine organisms through integrated research and development. Delivers innovative products to equip healthcare professionals with new tools to treat cancer.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to PharmaMar

BioNovion Logo

BioNovion

HQ: United States Website
  • Description: Provider of immune oncology antibody discovery and development focused on antibodies for the immune therapy of cancer; U.S.-based, founded in 2011 and acquired by Aduro BioTech in 2015.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioNovion company profile →
Circle Pharma Logo

Circle Pharma

HQ: United States Website
  • Description: Provider of bioavailable macrocyclic peptide therapeutics targeting intracellular protein-protein interactions, supported by the MXMO platform that combines computational structure-based design and synthetic chemistry to create cell-permeable macrocycles. Offers cyclin A/B inhibitors for cancers with Retinoblastoma pathway mutations and other tumors, advancing precision oncology and therapeutics for 'undruggable' targets.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Circle Pharma company profile →
OncoEthix Logo

OncoEthix

HQ: Switzerland Website
  • Description: Provider of cancer drug development, advancing a portfolio of three to five promising oncology compounds through clinical development; a private Swiss company founded in 2007.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full OncoEthix company profile →
BioVie Logo

BioVie

HQ: United States Website
  • Description: Provider of biotechnological research and development focused on innovative therapies for the treatment of liver disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioVie company profile →
Regor Therapeutics Logo

Regor Therapeutics

HQ: United States Website
  • Description: Provider of clinical-stage discovery and development of medicines for oncology, metabolic, and autoimmune diseases, powered by its proprietary rCARD platform for accelerated drug discovery. Pipeline includes RGT-075, an oral once-daily GLP-1R agonist for obesity, and RGT-419B, a CDK4/6 inhibitor for advanced/metastatic breast cancer, showing efficacy in patients resistant to current therapies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Regor Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for PharmaMar

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to PharmaMar

2.2 - Growth funds investing in similar companies to PharmaMar

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for PharmaMar

4.2 - Public trading comparable groups for PharmaMar

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to PharmaMar

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About PharmaMar

What does PharmaMar do?

PharmaMar is a provider of oncology medicines inspired by the sea, discovering antitumor molecules from marine organisms through integrated research and development. Delivers innovative products to equip healthcare professionals with new tools to treat cancer.

Who are PharmaMar's competitors?

PharmaMar's competitors and similar companies include BioNovion, Circle Pharma, OncoEthix, BioVie, and Regor Therapeutics.

Where is PharmaMar headquartered?

PharmaMar is headquartered in Spain.

How many employees does PharmaMar have?

PharmaMar has 1,000 employees 🔒.

When was PharmaMar founded?

PharmaMar was founded in 2010 🔒.

What sector and industry vertical is PharmaMar in?

PharmaMar is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for PharmaMar

Who are the top strategic acquirers in PharmaMar's sector and industry

Top strategic M&A buyers and acquirers in PharmaMar's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for PharmaMar?

Top strategic M&A buyers groups and sectors for PharmaMar include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in PharmaMar's sector and industry vertical

Which are the top PE firms investing in PharmaMar's sector and industry vertical?

Top PE firms investing in PharmaMar's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in PharmaMar's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in PharmaMar's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in PharmaMar's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to PharmaMar include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in PharmaMar's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for PharmaMar?

The key public trading comparables and valuation benchmarks for PharmaMar include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for PharmaMar for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for PharmaMar with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in PharmaMar's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for PharmaMar with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in PharmaMar's' sector and industry vertical?

Access recent funding rounds and capital raises in PharmaMar's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for PharmaMar